Marta Díaz Silva
Investigador
Research group
The researcher Marta Díaz graduated in Biology in 1999 from the University of Barcelona and obtained a PhD in Biochemistry and Molecular Biology from the University of Barcelona in 2006.
That same year she joined the Hospital Sant Joan de Déu in the line of Research of the Dra. Lourdes Ibáñez as RETICS postdoctoral researcher. Since 2007, she has been a clinical researcher at CIBERDEM (Biomedical Research Center for Diabetes Networks and Associated Metabolic Diseases), Carlos III Health Institute, Madrid.
Since 2006, its research activity has focused on: on one hand, the characterization of endocrine-metabolic alterations, as well as certain genetic and epigenetic underlying retarded intrauterine growth; On the other hand, the study of the clinical efficacy of the combination therapy of low dose insulin sensitizers and antiandrogens in the treatment of ovarian hyperandrogenism in teenagers.
Professional network profiles
Last Publications
- Díaz-Silva M, Casano-Sancho P, Quesada T, Lopez-Bermejo A, de Zegher F, Villarroya-Gombau F and Ibañez-Toda L Circulating exosomes decrease in size and increase in number between birth and age 7: relations to fetal growth and liver fat Frontiers in Endocrinology . 14: 1257768-1257768.
- de Zegher F, Díaz-Silva M and Ibañez-Toda L Adolescent polycystic ovary syndrome without obesity: HOTAIR rs1443512 genotype relates to fat mass and to the redistribution of fat mass on low-dose pioglitazone JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION . : .
- García-Beltran C, Malpique R, Andersen, Marianne S., Bas, Firdevs, Bassols, Judit, Darendeliler, Feyza, Díaz-Silva M, Dieris, Barbara, Fanelli, Flaminia, Froehlich-Reiterer, Elke, Gambineri, Alessandra, Glintborg, Dorte, Lopez-Bermejo, Abel, Mann, Christopher, Marin, Silvia, Obermayer-Pietsch, Barbara, Odegard, Ronnaug, Ravn, Pernille, Reinehr, Thomas, Renzulli, Matteo, Salvador-Alarcon C, Singer, Viola, Vanky, Eszter, Torres, Juan Vicente, Yildiz, Melek, de Zegher, Francis and Ibañez-Toda L SPIOMET4HEALTH-efficacy, tolerability and safety of lifestyle intervention plus a fixed dose combination of spironolactone, pioglitazone and metformin (SPIOMET) for adolescent girls and young women with polycystic ovary syndrome: study protocol for a multicentre, randomised, double-blind, placebo-controlled, four-arm, parallel-group, phase II clinical trial Trials . 24(1): 589-589.
Projects
- Project name:
- Variaciones longitudinales del perfil de expresión de microRNAs exosomales en niños con bajo peso para la edad gestacional con y sin recuperación de peso y talla postnatal
- Leader
- Paula Casano Sancho, Marta Díaz Silva
- Funding entities:
- Casano Sancho, Paula, Instituto de Salud Carlos III (ISCIII), Fundació Privada per a la Recerca i la Docència Sant Joan de Déu - FSJD
- Code
- PI22/01424
- Starting - finishing date:
- 2023 - 2025
- Project name:
- Efectos del tratamiento con spiomet a mitad de dosis en niñas con pubertad adelantada y aceleración de la maduración ósea: estudio multicéntrico, aleatorizado y controlado con placebo
- Leader
- Lourdes Ibañez Toda
- Funding entities:
- Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta
- Code
- ICI21/00005
- Starting - finishing date:
- 2022 - 2025
- Project name:
- SPIOMET4HEALTH_PCOS in adolescent girls and young women: Toward a treatment guided by pathopsysiology
- Leader
- Lourdes Ibañez Toda
- Funding entities:
- European Commission
- Code
- 899671
- Starting - finishing date:
- 2021 - 2026